Financials
- Market Capitalization 8.44 M
- Employee 8
- Founded 2011
- CEO Paul Kang
- Website www.exicuretx.com
- Headquarter Delaware, United States
- FIGI BBG00GTJCSB4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.86
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4803 | IMNN Imunon, Inc. - Common Stock | 1.59 USD | -0.63% | -2.45% | +6.00% | -51.08% | 8.92 M USD | ||
| 4804 | TRAW Traws Pharma, Inc. - Common Stock | 0.58 USD | -1.69% | +9.43% | +16.00% | -59.15% | 8.91 M USD | ||
| 4812 | CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.52 USD | 0.00% | -3.16% | +10.40% | -12.38% | 8.07 M USD | ||
| 4816 | SNGX Soligenix, Inc. - Common Stock | 0.38 USD | 0.00% | -2.56% | +5.56% | -66.37% | 8.27 M USD |